From Preclinical Data to IND Filing: BioBoston’s Strategic Approach to Drug Development Success
The journey from preclinical research to an Investigational New Drug (IND) filing marks a pivotal phase in drug development. For […]
The journey from preclinical research to an Investigational New Drug (IND) filing marks a pivotal phase in drug development. For […]